European Archives - Page 182 of 1279 - European Medical Journal

Infectious Disease Diagnostics: Superbugs, Zoonotic Threats, and the Next Pandemic

In the second episode of our Infectious Disease Diagnostics series, Jonathan is joined by molecular epidemiologist Rodney Rohde to explore diagnostic innovations in the fight against antimicrobial resistance and gaps in zoonotic disease detection.

Seasonal Immunotherapy: Safe to Start During Pollen Peaks?

The study suggests that initiating Artemisia annua SLIT during the pollen season is just as safe and well-tolerated as starting it before.

24 Apr 2025

Case Report of a Patient Presenting with Acute Flank Pain

A female in her 40s, with a history of heavy smoking presented to the emergency department with a 6-hour history of paraesthesia and…

Probiotics Improve Liver Function During Chemotherapy

A recent study explored the combined impact of oral nutritional supplementation and probiotics on gut microbiota and liver function.

Biomimetic Hydrogels Revolutionise CAR T Cancer Therapy Production

Biomimetic hydrogels boost CAR T cell production by 50%, cutting cancer therapy costs.

Caffeine Could Help Reduce Cardiovascular Risk in Lupus

A study finds that caffeine intake improves endothelial function in systemic lupus erythematosus by enhancing cell survival and reducing inflammation.

Breakthrough Study Links Parasitic Infection to Cervical Cancer Risk

Research presented at ESCMID Global 2025 reveals how Schistosoma haematobium infection and praziquantel treatment may trigger gene activity linked to cervical cancer risk in women.

Handshake on blue background

Boehringer and Tessellate partner to tackle tough cancer targets

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies.

Climatic Factors Drive Oropouche Virus Spread Across Latin America

A large-scale study has identified key predictors of Oropouche virus transmission risk across Latin America, providing insights into the 2023–24 outbreak.

Weighing up the Risks: GI Side Effects of Semaglutide vs Tirzepatide

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!